img

Global and United States Consumer Healthcare Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Consumer Healthcare Drug Market Report & Forecast 2024-2034

Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
Market Analysis and InsightsGlobal and United States Consumer Healthcare Drug Market
This report focuses on global and United States Consumer Healthcare Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Consumer Healthcare Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Consumer Healthcare Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Consumer Healthcare Drug include Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Takeda, Bayer and Teva, etc. The global five biggest players hold a share of % in 2024.
Global Consumer Healthcare Drug Scope and Market Size
Consumer Healthcare Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Consumer Healthcare Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Consumer Healthcare Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Segment by Type
Solid Preparations
Oral Liquid
Patch
Other

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Consumer Healthcare Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Consumer Healthcare Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Consumer Healthcare Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Consumer Healthcare Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Consumer Healthcare Drug Product Introduction
1.2 Global Consumer Healthcare Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Consumer Healthcare Drug Market Size for the Year 2018-2034
1.2.2 United States Consumer Healthcare Drug Market Size for the Year 2018-2034
1.3 Consumer Healthcare Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Consumer Healthcare Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Consumer Healthcare Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Consumer Healthcare Drug Market Dynamics
1.4.1 Consumer Healthcare Drug Industry Trends
1.4.2 Consumer Healthcare Drug Market Drivers
1.4.3 Consumer Healthcare Drug Market Challenges
1.4.4 Consumer Healthcare Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Consumer Healthcare Drug by Type
2.1 Consumer Healthcare Drug Market Segment by Type
2.1.1 Solid Preparations
2.1.2 Oral Liquid
2.1.3 Patch
2.1.4 Other
2.2 Global Consumer Healthcare Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global Consumer Healthcare Drug Market Size by Type (2018-2034)
2.4 United States Consumer Healthcare Drug Market Size by Type (2018, 2024 & 2034)
2.5 United States Consumer Healthcare Drug Market Size by Type (2018-2034)
3 Consumer Healthcare Drug by Application
3.1 Consumer Healthcare Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Other
3.2 Global Consumer Healthcare Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global Consumer Healthcare Drug Market Size by Application (2018-2034)
3.4 United States Consumer Healthcare Drug Market Size by Application (2018, 2024 & 2034)
3.5 United States Consumer Healthcare Drug Market Size by Application (2018-2034)
4 Global Consumer Healthcare Drug Competitor Landscape by Company
4.1 Global Consumer Healthcare Drug Market Size by Company
4.1.1 Global Key Companies of Consumer Healthcare Drug, Ranked by Revenue (2024)
4.1.2 Global Consumer Healthcare Drug Revenue by Player (2018-2023)
4.2 Global Consumer Healthcare Drug Concentration Ratio (CR)
4.2.1 Consumer Healthcare Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Consumer Healthcare Drug in 2024
4.2.3 Global Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Consumer Healthcare Drug Head office and Area Served
4.4 Global Key Players of Consumer Healthcare Drug, Product and Application
4.5 Global Key Players of Consumer Healthcare Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Consumer Healthcare Drug Market Size by Company
4.7.1 Key Players of Consumer Healthcare Drug in United States, Ranked by Revenue (2024)
4.7.2 United States Consumer Healthcare Drug Revenue by Players (2021, 2024 & 2023)
5 Global Consumer Healthcare Drug Market Size by Region
5.1 Global Consumer Healthcare Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Consumer Healthcare Drug Market Size by Region (2018-2034)
5.2.1 Global Consumer Healthcare Drug Market Size by Region: 2018-2023
5.2.2 Global Consumer Healthcare Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas Consumer Healthcare Drug Market Size YoY Growth 2018-2034
6.2 Americas Consumer Healthcare Drug Market Size by Type
6.2.1 Americas Consumer Healthcare Drug Market Size by Type (2018-2023)
6.2.2 Americas Consumer Healthcare Drug Market Size by Type (2024-2034)
6.2.3 Americas Consumer Healthcare Drug Market Share by Type (2018-2034)
6.3 Americas Consumer Healthcare Drug Market Size by Application
6.3.1 Americas Consumer Healthcare Drug Market Size by Application (2018-2023)
6.3.2 Americas Consumer Healthcare Drug Market Size by Application (2024-2034)
6.3.3 Americas Consumer Healthcare Drug Market Share by Application (2018-2034)
6.4 Americas Consumer Healthcare Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Consumer Healthcare Drug Market Size YoY Growth 2018-2034
7.2 EMEA Consumer Healthcare Drug Market Size by Type
7.2.1 EMEA Consumer Healthcare Drug Market Size by Type (2018-2023)
7.2.2 EMEA Consumer Healthcare Drug Market Size by Type (2024-2034)
7.2.3 EMEA Consumer Healthcare Drug Market Share by Type (2018-2034)
7.3 EMEA Consumer Healthcare Drug Market Size by Application
7.3.1 EMEA Consumer Healthcare Drug Market Size by Application (2018-2023)
7.3.2 EMEA Consumer Healthcare Drug Market Size by Application (2024-2034)
7.3.3 EMEA Consumer Healthcare Drug Market Share by Application (2018-2034)
7.4 EMEA Consumer Healthcare Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Consumer Healthcare Drug Market Size YoY Growth 2018-2034
8.2 China Consumer Healthcare Drug Market Size by Type
8.2.1 China Consumer Healthcare Drug Market Size by Type (2018-2023)
8.2.2 China Consumer Healthcare Drug Market Size by Type (2024-2034)
8.2.3 China Consumer Healthcare Drug Market Share by Type (2018-2034)
8.3 China Consumer Healthcare Drug Market Size by Application
8.3.1 China Consumer Healthcare Drug Market Size by Application (2018-2023)
8.3.2 China Consumer Healthcare Drug Market Size by Application (2024-2034)
8.3.3 China Consumer Healthcare Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Consumer Healthcare Drug Market Size YoY Growth 2018-2034
9.2 APAC Consumer Healthcare Drug Market Size by Type
9.2.1 APAC Consumer Healthcare Drug Market Size by Type (2018-2023)
9.2.2 APAC Consumer Healthcare Drug Market Size by Type (2024-2034)
9.2.3 APAC Consumer Healthcare Drug Market Share by Type (2018-2034)
9.3 APAC Consumer Healthcare Drug Market Size by Application
9.3.1 APAC Consumer Healthcare Drug Market Size by Application (2018-2023)
9.3.2 APAC Consumer Healthcare Drug Market Size by Application (2024-2034)
9.3.3 APAC Consumer Healthcare Drug Market Share by Application (2018-2034)
9.4 APAC Consumer Healthcare Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Details
10.1.2 Johnson & Johnson Business Overview
10.1.3 Johnson & Johnson Consumer Healthcare Drug Introduction
10.1.4 Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2018-2023)
10.1.5 Johnson & Johnson Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Details
10.2.2 AbbVie Business Overview
10.2.3 AbbVie Consumer Healthcare Drug Introduction
10.2.4 AbbVie Revenue in Consumer Healthcare Drug Business (2018-2023)
10.2.5 AbbVie Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Company Details
10.3.2 Merck & Co. Business Overview
10.3.3 Merck & Co. Consumer Healthcare Drug Introduction
10.3.4 Merck & Co. Revenue in Consumer Healthcare Drug Business (2018-2023)
10.3.5 Merck & Co. Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Details
10.4.2 GlaxoSmithKline Business Overview
10.4.3 GlaxoSmithKline Consumer Healthcare Drug Introduction
10.4.4 GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2018-2023)
10.4.5 GlaxoSmithKline Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Pfizer Business Overview
10.5.3 Pfizer Consumer Healthcare Drug Introduction
10.5.4 Pfizer Revenue in Consumer Healthcare Drug Business (2018-2023)
10.5.5 Pfizer Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Details
10.6.2 Sanofi Business Overview
10.6.3 Sanofi Consumer Healthcare Drug Introduction
10.6.4 Sanofi Revenue in Consumer Healthcare Drug Business (2018-2023)
10.6.5 Sanofi Recent Development
10.7 Takeda
10.7.1 Takeda Company Details
10.7.2 Takeda Business Overview
10.7.3 Takeda Consumer Healthcare Drug Introduction
10.7.4 Takeda Revenue in Consumer Healthcare Drug Business (2018-2023)
10.7.5 Takeda Recent Development
10.8 Bayer
10.8.1 Bayer Company Details
10.8.2 Bayer Business Overview
10.8.3 Bayer Consumer Healthcare Drug Introduction
10.8.4 Bayer Revenue in Consumer Healthcare Drug Business (2018-2023)
10.8.5 Bayer Recent Development
10.9 Teva
10.9.1 Teva Company Details
10.9.2 Teva Business Overview
10.9.3 Teva Consumer Healthcare Drug Introduction
10.9.4 Teva Revenue in Consumer Healthcare Drug Business (2018-2023)
10.9.5 Teva Recent Development
10.10 Sinopharm Group
10.10.1 Sinopharm Group Company Details
10.10.2 Sinopharm Group Business Overview
10.10.3 Sinopharm Group Consumer Healthcare Drug Introduction
10.10.4 Sinopharm Group Revenue in Consumer Healthcare Drug Business (2018-2023)
10.10.5 Sinopharm Group Recent Development
10.11 CR Pharmaceutical
10.11.1 CR Pharmaceutical Company Details
10.11.2 CR Pharmaceutical Business Overview
10.11.3 CR Pharmaceutical Consumer Healthcare Drug Introduction
10.11.4 CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2023)
10.11.5 CR Pharmaceutical Recent Development
10.12 Shanghai Pharmaceuticals
10.12.1 Shanghai Pharmaceuticals Company Details
10.12.2 Shanghai Pharmaceuticals Business Overview
10.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Introduction
10.12.4 Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2018-2023)
10.12.5 Shanghai Pharmaceuticals Recent Development
10.13 Hualan Bio
10.13.1 Hualan Bio Company Details
10.13.2 Hualan Bio Business Overview
10.13.3 Hualan Bio Consumer Healthcare Drug Introduction
10.13.4 Hualan Bio Revenue in Consumer Healthcare Drug Business (2018-2023)
10.13.5 Hualan Bio Recent Development
10.14 North China Pharmaceutical
10.14.1 North China Pharmaceutical Company Details
10.14.2 North China Pharmaceutical Business Overview
10.14.3 North China Pharmaceutical Consumer Healthcare Drug Introduction
10.14.4 North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2023)
10.14.5 North China Pharmaceutical Recent Development
10.15 Hengrui Medicine
10.15.1 Hengrui Medicine Company Details
10.15.2 Hengrui Medicine Business Overview
10.15.3 Hengrui Medicine Consumer Healthcare Drug Introduction
10.15.4 Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2018-2023)
10.15.5 Hengrui Medicine Recent Development
10.16 Fosun Pharma
10.16.1 Fosun Pharma Company Details
10.16.2 Fosun Pharma Business Overview
10.16.3 Fosun Pharma Consumer Healthcare Drug Introduction
10.16.4 Fosun Pharma Revenue in Consumer Healthcare Drug Business (2018-2023)
10.16.5 Fosun Pharma Recent Development
10.17 East China Medicine
10.17.1 East China Medicine Company Details
10.17.2 East China Medicine Business Overview
10.17.3 East China Medicine Consumer Healthcare Drug Introduction
10.17.4 East China Medicine Revenue in Consumer Healthcare Drug Business (2018-2023)
10.17.5 East China Medicine Recent Development
10.18 Livzon Group
10.18.1 Livzon Group Company Details
10.18.2 Livzon Group Business Overview
10.18.3 Livzon Group Consumer Healthcare Drug Introduction
10.18.4 Livzon Group Revenue in Consumer Healthcare Drug Business (2018-2023)
10.18.5 Livzon Group Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Consumer Healthcare Drug Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Consumer Healthcare Drug Market Trends
Table 3. Consumer Healthcare Drug Market Drivers
Table 4. Consumer Healthcare Drug Market Challenges
Table 5. Consumer Healthcare Drug Market Restraints
Table 6. Global Consumer Healthcare Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Consumer Healthcare Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Consumer Healthcare Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Consumer Healthcare Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Consumer Healthcare Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Consumer Healthcare Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Consumer Healthcare Drug Revenue Share by Player, 2018-2023
Table 13. Global Consumer Healthcare Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Consumer Healthcare Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Consumer Healthcare Drug as of 2024)
Table 15. Global Key Players of Consumer Healthcare Drug, Headquarters and Area Served
Table 16. Global Key Players of Consumer Healthcare Drug, Product and Application
Table 17. Global Key Players of Consumer Healthcare Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Consumer Healthcare Drug in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Consumer Healthcare Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Consumer Healthcare Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Consumer Healthcare Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Consumer Healthcare Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Consumer Healthcare Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Consumer Healthcare Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Consumer Healthcare Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Consumer Healthcare Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Consumer Healthcare Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Consumer Healthcare Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Consumer Healthcare Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Consumer Healthcare Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Consumer Healthcare Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Consumer Healthcare Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Consumer Healthcare Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Consumer Healthcare Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Consumer Healthcare Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Consumer Healthcare Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Consumer Healthcare Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Consumer Healthcare Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Consumer Healthcare Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Consumer Healthcare Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Consumer Healthcare Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Consumer Healthcare Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Consumer Healthcare Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Consumer Healthcare Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. Johnson & Johnson Company Details
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Consumer Healthcare Drug Product
Table 54. Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. AbbVie Company Details
Table 57. AbbVie Business Overview
Table 58. AbbVie Consumer Healthcare Drug Product
Table 59. AbbVie Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 60. AbbVie Recent Development
Table 61. Merck & Co. Company Details
Table 62. Merck & Co. Business Overview
Table 63. Merck & Co. Consumer Healthcare Drug Product
Table 64. Merck & Co. Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 65. Merck & Co. Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Consumer Healthcare Drug Product
Table 69. GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Consumer Healthcare Drug Product
Table 74. Pfizer Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Consumer Healthcare Drug Product
Table 79. Sanofi Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Consumer Healthcare Drug Product
Table 84. Takeda Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 85. Takeda Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Consumer Healthcare Drug Product
Table 89. Bayer Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Teva Company Details
Table 92. Teva Business Overview
Table 93. Teva Consumer Healthcare Drug Product
Table 94. Teva Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 95. Teva Recent Development
Table 96. Sinopharm Group Company Details
Table 97. Sinopharm Group Business Overview
Table 98. Sinopharm Group Consumer Healthcare Drug Product
Table 99. Sinopharm Group Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 100. Sinopharm Group Recent Development
Table 101. CR Pharmaceutical Company Details
Table 102. CR Pharmaceutical Business Overview
Table 103. CR Pharmaceutical Consumer Healthcare Drug Product
Table 104. CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 105. CR Pharmaceutical Recent Development
Table 106. Shanghai Pharmaceuticals Company Details
Table 107. Shanghai Pharmaceuticals Business Overview
Table 108. Shanghai Pharmaceuticals Consumer Healthcare Drug Product
Table 109. Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 110. Shanghai Pharmaceuticals Recent Development
Table 111. Hualan Bio Company Details
Table 112. Hualan Bio Business Overview
Table 113. Hualan Bio Consumer Healthcare Drug Product
Table 114. Hualan Bio Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 115. Hualan Bio Recent Development
Table 116. North China Pharmaceutical Company Details
Table 117. North China Pharmaceutical Business Overview
Table 118. North China Pharmaceutical Consumer Healthcare Drug Product
Table 119. North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 120. North China Pharmaceutical Recent Development
Table 121. Hengrui Medicine Company Details
Table 122. Hengrui Medicine Business Overview
Table 123. Hengrui Medicine Consumer Healthcare Drug Product
Table 124. Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 125. Hengrui Medicine Recent Development
Table 126. Fosun Pharma Company Details
Table 127. Fosun Pharma Business Overview
Table 128. Fosun Pharma Consumer Healthcare Drug Product
Table 129. Fosun Pharma Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 130. Fosun Pharma Recent Development
Table 131. East China Medicine Company Details
Table 132. East China Medicine Business Overview
Table 133. East China Medicine Consumer Healthcare Drug Product
Table 134. East China Medicine Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 135. East China Medicine Recent Development
Table 136. Livzon Group Company Details
Table 137. Livzon Group Business Overview
Table 138. Livzon Group Consumer Healthcare Drug Product
Table 139. Livzon Group Revenue in Consumer Healthcare Drug Business (2018-2023) & (US$ Million)
Table 140. Livzon Group Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Consumer Healthcare Drug Product Picture
Figure 2. Global Consumer Healthcare Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Consumer Healthcare Drug Market Size 2018-2034 (US$ Million)
Figure 4. United States Consumer Healthcare Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Consumer Healthcare Drug Market Size 2018-2034 (US$ Million)
Figure 6. United States Consumer Healthcare Drug Market Share in Global 2018-2034
Figure 7. Consumer Healthcare Drug Report Years Considered
Figure 8. Product Picture of Solid Preparations
Figure 9. Product Picture of Oral Liquid
Figure 10. Product Picture of Patch
Figure 11. Product Picture of Other
Figure 12. Global Consumer Healthcare Drug Market Share by Type in 2024 & 2034
Figure 13. Global Consumer Healthcare Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 14. Global Consumer Healthcare Drug Market Share by Type (2018-2034)
Figure 15. United States Consumer Healthcare Drug Market Share by Type in 2024 & 2034
Figure 16. United States Consumer Healthcare Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 17. United States Consumer Healthcare Drug Market Share by Type (2018-2034)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Retail Pharmacy
Figure 20. Product Picture of Other
Figure 21. Global Consumer Healthcare Drug Market Share by Application in 2024 & 2034
Figure 22. Global Consumer Healthcare Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 23. Global Consumer Healthcare Drug Market Share by Application (2018-2034)
Figure 24. United States Consumer Healthcare Drug Market Share by Application in 2024 & 2034
Figure 25. United States Consumer Healthcare Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 26. United States Consumer Healthcare Drug Market Share by Application (2018-2034)
Figure 27. The Top 5 and 10 Largest Companies of Consumer Healthcare Drug in the World: Market Share by Consumer Healthcare Drug Revenue in 2024
Figure 28. Global Consumer Healthcare Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 29. Global Consumer Healthcare Drug Market Share by Region (2018-2034)
Figure 30. Americas Consumer Healthcare Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 31. Americas Consumer Healthcare Drug Market Share by Type (2018-2034)
Figure 32. Americas Consumer Healthcare Drug Market Share by Application (2018-2034)
Figure 33. United States Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Canada Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Mexico Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Brazil Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. EMEA Consumer Healthcare Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 38. EMEA Consumer Healthcare Drug Market Share by Type (2018-2034)
Figure 39. EMEA Consumer Healthcare Drug Market Share by Application (2018-2034)
Figure 40. Europe Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. Middle East Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Africa Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. China Consumer Healthcare Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 44. China Consumer Healthcare Drug Market Share by Type (2018-2034)
Figure 45. China Consumer Healthcare Drug Market Share by Application (2018-2034)
Figure 46. APAC Consumer Healthcare Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 47. APAC Consumer Healthcare Drug Market Share by Type (2018-2034)
Figure 48. APAC Consumer Healthcare Drug Market Share by Application (2018-2034)
Figure 49. Japan Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. South Korea Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. China Taiwan Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. Southeast Asia Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. India Consumer Healthcare Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. Johnson & Johnson Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 56. Merck & Co. Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 60. Takeda Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 61. Bayer Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 62. Teva Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 63. Sinopharm Group Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 64. CR Pharmaceutical Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 65. Shanghai Pharmaceuticals Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 66. Hualan Bio Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 67. North China Pharmaceutical Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 68. Hengrui Medicine Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 69. Fosun Pharma Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 70. East China Medicine Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 71. Livzon Group Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries